{
  "summary": {
    "n_positive_cases": 25,
    "n_false_negatives": 1,
    "fn_rate": 0.04,
    "fn_rate_percent": 4.0,
    "category_breakdown": {
      "drug_not_found": 1
    }
  },
  "false_negative_cases": [
    {
      "drug": "nusinersen",
      "disease": "spinal muscular atrophy",
      "raw_score": 0.0,
      "rank": null,
      "min_score_expected": 0.0,
      "category": "drug_not_found",
      "remediation": "Drug not in candidate list at all. Likely causes: (1) Drug name in validation_dataset.py does not match ChEMBL preferred name. (2) Drug has no targets from DGIdb or fallback. (3) Drug filtered out before scoring. Check: data_fetcher.py logs for this drug name.",
      "mechanism": "Antisense oligonucleotide promoting SMN2 exon 7 inclusion",
      "sources": [
        "PMID:28056917"
      ],
      "notes": "KNOWN LIMITATION: max_phase=3, not in ChEMBL approved pool. drug_not_found expected. Case documents ASO coverage gap."
    }
  ],
  "diagnostics": {
    "fallback_dependency": {
      "drugs_at_risk_of_fallback_issues": [],
      "fallback_counter_note": "data_fetcher.py logs a 'Using fallback targets' message each time the KNOWN_BIOLOGIC_TARGETS / KNOWN_SMALL_MOLECULE_TARGETS fallback is triggered. To count these for the paper Methods section: grep the run log for 'Using fallback targets' and count occurrences. TODO: Add _fallback_usage_count to pipeline diagnostics output so this script can surface the count automatically.",
      "methods_disclosure_required": "The paper Methods section must disclose: 'When all live API sources (ChEMBL, DGIdb) returned zero targets for an approved drug, the pipeline fell back to a curated last-resort target list (KNOWN_BIOLOGIC_TARGETS, KNOWN_SMALL_MOLECULE_TARGETS) derived from primary pharmacological literature (FDA product labels, peer-reviewed pharmacology references). This fallback was triggered for [N] drugs in the validation set and [M] drugs in the full analysis. The full fallback list is available in data_fetcher.py and as Supplementary Table S{X}.'"
    },
    "sparse_disease_genes": {
      "infantile hemangioma": "Rare pediatric condition; limited OT associations",
      "paroxysmal nocturnal hemoglobinuria": "Rare; complement pathway genes may be sparse",
      "cytokine release syndrome": "Syndrome (not disease); non-deterministic OT results",
      "tuberous sclerosis": "mTOR genes present but disease called 'tuberous sclerosis complex'"
    },
    "recommended_investigations": [
      "1. Check data_fetcher.py logs for each FN drug \u2014 did it log    'Using fallback targets'? If not, was it in DGIdb?",
      "2. For score_below_threshold cases: check which genes/pathways    were returned by OpenTargets for each disease.",
      "3. For drug_not_found cases: verify drug name in ChEMBL matches    validation_dataset.py (try 'imatinib mesylate' vs 'imatinib').",
      "4. For disease_not_found cases: add alias to DISEASE_ALIASES in    data_fetcher.py.",
      "5. After fixes: re-run validate_all.sh and confirm FN count decreases."
    ]
  }
}